Financial statements Zakłady Chemiczno-Farmaceutyczne Vis
Balance sheet data of ZAKŁADY CHEMICZNO-FARMACEUTYCZNE VIS
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
|---|---|---|---|---|---|---|---|
| Total assets | 4 922 174,72 | 4 545 876,98 | 6 502 303,98 | 6 794 992,08 | 7 550 524,89 | 7 860 977,79 | 8 157 949,30 |
| A. Fixed assets | 982 074,10 | 947 250,07 | 1 111 035,99 | 2 901 658,11 | 3 952 687,80 | 3 950 503,87 | 3 711 220,45 |
| B. Current assets | 3 940 100,62 | 3 598 626,91 | 5 391 267,99 | 3 893 333,97 | 3 597 837,09 | 3 910 473,92 | 4 446 728,85 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | - | - | - | - |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | - | - | - | - |
| Total liabilities | 4 922 174,72 | 4 545 876,98 | 6 502 303,98 | 6 794 992,08 | 7 550 524,89 | 7 860 977,79 | 8 157 949,30 |
| A. Equity | 4 787 238,79 | 4 292 866,30 | 5 274 704,38 | 6 177 100,40 | 6 305 495,72 | 6 987 196,54 | 7 074 887,44 |
| B. Liabilities and provisions for liabilities | 134 935,93 | 253 010,68 | 1 227 599,60 | 617 891,68 | 1 245 029,17 | 873 781,25 | 1 083 061,86 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | - | 455 435,24 | 324 443,58 | 185 496,80 |
| II. Short-term liabilities | 134 935,93 | 253 010,68 | 1 227 599,60 | 617 891,68 | 789 593,93 | 549 337,67 | 897 565,06 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.
AD
AD